Abstract:Hydatidiform mole is classified into partial and complete subtypes according to histopathological and genetic criteria. Distinction between the two by histology alone may be difficult. Genetically, a complete mole is diploid without maternal contribution, whereas a partial mole is triploid with a maternal chromosome complement. To assess the accuracy of histological diagnosis by correlating with the genetic composition, we performed fluorescent microsatellite genotyping to detect the presence or absence of maternal genome in a hydatidiform mole and carried out chromosome in situ hybridization to analyze the ploidy. For genotyping analysis, paraffin sections of 36 complete and nine partial moles, diagnosed according to histological criteria, were microdissected and DNA was separately extracted from the decidua and molar villi. Six pairs of primers that flank polymorphic microsatellite repeat sequences on five different chromosomes were used. In all, 34 cases, including 31 complete moles and three partial moles diagnosed histologically, showed no maternal contribution by genotyping; thus these could be genetically considered as complete mole. The other 11 cases (five complete moles and six partial moles previously diagnosed by histology) showed the presence of maternal contribution and were genetically diagnosed as partial moles. The genotyping results correlated with histological evaluation in 88% (37/45) of hydatidiform mole and correlated with chromosome in situ hybridization findings in all the cases, that is, triploid hydatidiform moles had maternal-derived alleles, while diploid hydatidiform moles were purely androgenetic. Compared with genetic diagnosis, histological evaluation was more reliable for the diagnosis of a complete mole (91%, 31/34) than that of a partial mole (55%, 6/11) (P=0.0033). Seven complete moles and three partial moles diagnosed genetically developed gestational trophoblastic neoplasia. To conclude, genotyping and chromosome in situ hybridization can provide reliable adjunct to histology for the classification of a hydatidiform mole, especially in cases with difficult histological evaluation and early gestational age. As a partial mole still carries a risk of developing gestational trophoblastic neoplasia, follow-up is considered necessary for both complete and partial moles.

Gestational Trophoblastic Disease: Contemporary Diagnostic Approach

Gestational trophoblastic disease: an update

Pathology of Gestational Trophoblastic Disease (GTD)

Diagnosis and management of gestational trophoblastic disease: 2021 update

Advances in diagnostics and management of gestational trophoblastic disease

Update on the diagnosis and management of gestational trophoblastic disease

Molecular Basis of Hydatidiform Moles-A Systematic Review

Challenges in Diagnosing Hydatidiform Moles: a Review of Promising Molecular Biomarkers.

Current chemotherapeutic options for the treatment of gestational trophoblastic disease

Diagnosis and Treatment of Gestational Trophoblastic Neoplasia

Clinical analysis of recurrent gestational trophoblastic neoplasia

Development in clinical diagnosis of gestational trophoblastic tumors

Explore the Non-mole Gestational Trophoblastic Tumor by Reviewing 62 Clinical Cases

Trophoblastic disease and choriocarcinoma

[GESTATIONAL TROPHOBLASTIC DISEASE: THE NEED FOR CENTRALIZATION OF TREATMENT CENTERS IN ISRAEL]

Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets

Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)

Management of trophoblastic tumors : review of evidence, current practice, and future directions

Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy

Analysis of Gestational Trophoblastic Disease by Genotyping and Chromosome in Situ Hybridization.

Review of current literature on gestational trophoblastic neoplasia